EP3687562
TREATMENT OF RECURRENT IDIOPATHIC PERICARDITIS BY DELIVERY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST FUSION PROTEIN
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.9.2018EP published:
19.3.2025EP application number:
18786587.8
EPO information:
European Patent Register
Max expiry date:
25.9.2038
Title in English:
TREATMENT OF RECURRENT IDIOPATHIC PERICARDITIS BY DELIVERY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST FUSION PROTEINLanguage of the patent:
English
Timeline
Today
26.9.2018EP application
19.3.2025EP Publication
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Inventor
Name:
TESSARI, EbenAddress:
Lexington MA 02421, US
Name:
PAOLINI, JohnAddress:
Lexington MA 02421, US
Priority
Number:
201762563387 PDate:
26.9.2017Country:
US
Number:
201862616819 PDate:
12.1.2018Country:
US
Number:
201862625075 PDate:
1.2.2018Country:
US
Number:
201862639425 PDate:
6.3.2018Country:
US
Number:
201862654291 PDate:
6.4.2018Country:
US
Number:
201862691552 PDate:
28.6.2018Country:
US
Number:
201862716331 PDate:
8.8.2018Country:
US
Classification
Categories:
A61K 38/17, A61K 39/395, A61K 47/68, A61P 9/00, A61P 29/00, A61K 38/20